Quarterly ResultMay 11, 2026, 05:07 PM
Biomea Fusion Reports Q1 Net Loss $12.4M; Going Concern Doubt
AI Summary
Biomea Fusion reported a net loss of $12.4 million for Q1 2026, a significant improvement from $29.3 million in Q1 2025. However, the company's management expressed substantial doubt about its ability to continue as a going concern, citing insufficient financial resources for the next twelve months. Cash and cash equivalents decreased to $44.7 million from $55.8 million at year-end 2025.
Key Highlights
- Substantial doubt about Biomea Fusion's ability to continue as a going concern.
- Q1 2026 net loss of $12.4 million, down from $29.3 million in Q1 2025.
- Net loss per common share improved to $(0.17) from $(0.80) year-over-year.
- Cash and cash equivalents decreased to $44.7 million from $55.8 million.
- Research and development expenses fell to $9.1 million from $22.9 million.
- General and administrative expenses decreased to $3.7 million from $6.8 million.
- Net cash used in operating activities was $11.7 million, down from $25.7 million.
- Accumulated deficit reached $461.5 million as of March 31, 2026.